Device for the verification of the dose delivered in radiotherapeutic medical applications and for quality controls of the radiation beams.
Proprietario: Università degli Studi di Trieste
ilo@amm.units.it
Method for the production of an IgM antibody for diagnosis and treatment of tumors expressing the tumor-associated antigen Glypican-1 (GPC1).
New characterization of asynchrony based exclusively on pressure and flow data and a method for their automatic recognition.
Substrate production process and predictive model, based on spectral data, to carry out biofluid samples analysis.
Method for the development of new homogeneous catalysts for the synthesis of functionalized polyolefins, active in mild reaction conditions.
Inhibiting the TGS1 enzyme and elongation of telomeres, to counteract the progression of pathologies caused by short telomeres.
Platform that enables advanced medication through devices usable as smart wound dressings for controlled drug deliver triggered by a stimulus.
Delivery of mir-126 for the targeted treatment of the tumor, with a low pharmacological dose and with reduced secondary side effects.
Determination of the spin-spin relaxation time of the sputum produced by patients voluntary expectoration for lung function / inflammation monitoring.
New compounds capable of modulating BDNF, for the development of drugs for the treatment of neurodegenerative and neuropsychiatric diseases.
Method that allows to indirectly evaluate lung function in a fast way, enabling a correct management of lung infection and preventing further lung damage.
New series of light-curing amphipathic antibacterial monomers of the quaternary ammonium salt type, for orthodontic treatment.
In vitro method for predicting the risk or prognosis of a Covid-19 infection in overweight and / or obese subjects.